-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Sempra, Lowers Price Target to $98

Benzinga·11/06/2025 15:02:49
Listen to the news
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $101 to $98.